allogene.com

Webside score allogene.com

Home - Allogene

 Genereret April 10 2026 06:02 AM

Gammel data? OPDATER !

Scoren er 49/100

SEO Indhold

Titel

Home - Allogene

Længde : 15

Perfekt, din titel indeholder mellem 10 og 70 bogstaver.

Beskrivelse

Længde : 0

Meget kritisk. Vi kan ikke finde en meta beskrivelse på dit website! Brug denne gratis meta generator til at lave beskrivelser.

Nøgleord

Dårligt! Vi kan ikke finde nogle meta nøgleord på din side! Brug denne gratis online meta generator for at oprette nye nøgleord.

Og Meta Egenskaber

Godt, din side benytter Og egenskaberne

Egenskab Indhold
locale en_US
type website
title Home - Allogene
description REDEFINING THE FUTURE OF CELL THERAPY WITH OUR AlloCAR T PRODUCT PLATFORM INNOVATION Multiplex gene-engineering and gene-editing capabilities Proprietary lymphodepletion platform State-of-the-art manufacturing Opportunity for product optimization SEE OUR PIONEERING PLATFORM >> KEY PROGRAMS Cemacabtagene ansegedleucel (cema-cel): Frontline treatment in LBCL, including diffuse large B-cell lymphoma (DLBCL) ALLO-316: ccRCC ALLO-329: autoimmune disease EXPLORE OUR PIPELINE >> LEADERSHIP A […]
url https://allogene.com/
site_name Allogene
image https://allogene.com/wp-content/uploads/2021/09/innovation.png

Overskrifter

H1 H2 H3 H4 H5 H6
4 10 21 0 0 0
  • [H1] RESOLUTION
  • [H1] REDEFINING THE FUTURE OF CAR T
  • [H1] RESOLUTION
  • [H1] REDEFINING THE FUTURE OF CAR T
  • [H2] NOW ENROLLING
  • [H2] NOW ENROLLING
  • [H2] Now Enrolling
  • [H2] NOW ENROLLING
  • [H2] REDEFINING THE FUTURE OF CELL THERAPY WITH OUR AlloCAR T PRODUCT PLATFORM
  • [H2] WE DON’T JUST SEE THE FUTURE.
  • [H2] WE KNOW HOW TO GET THERE.
  • [H2] WHY ALLOGENEIC CELL PRODUCTS HAVE THE POTENTIAL TO DO WHAT NO AUTOLOGOUS CAR T HAS DONE BEFORE
  • [H2] OUR PARTNERS
  • [H2] LATEST NEWS
  • [H3] INNOVATION
  • [H3] KEY PROGRAMS
  • [H3] LEADERSHIP
  • [H3] ACCESS
  • [H3] COST
  • [H3] SPEED/RELIABILITY
  • [H3] INNOVATION
  • [H3] Mar 12, 2026
  • [H3] Mar 2, 2026
  • [H3] Feb 5, 2026
  • [H3] Jan 8, 2026
  • [H3] Dec 15, 2025
  • [H3] Nov 10, 2025
  • [H3] Nov 6, 2025
  • [H3] Nov 3, 2025
  • [H3] Oct 30, 2025
  • [H3] Aug 27, 2025
  • [H3] Aug 13, 2025
  • [H3] Aug 6, 2025
  • [H3] CONNECT
  • [H3] CONNECT

Billeder

Vi fandt 18 billeder på denne side.

3 alt tags mangler eller er tomme. Tilføj alternativ tekst til dine billeder for at gøre siden mere brugervenlig, og for at optimere din SEO i forhold til søgemaskinerne.

Text/HTML balance

Balance : 1%

Denne sides text til HTML fordeling er under 15 procent, dette betyder at din side mangler indhold!

Flash

Perfekt, ingen Flash objekter er blevet fundet på siden.

iFrame

Perfekt, der er ikke nogen iFrames på din side!

URL Omskrivning

Godt. Dine links ser venlige ud!

Underscores i links

Perfekt! Ingen underscores blev fundet i dine links

On-page links

Vi fandt et total af 71 links inkluderende 0 link(s) til filer

Anker Type Juice
Skip to content Intern Sender Juice
CONTACT US Intern Sender Juice
CAREERS Intern Sender Juice
PIPELINE Intern Sender Juice
AlloCAR T PRODUCT PIPELINE Intern Sender Juice
THE ALPHA3 TRIAL Intern Sender Juice
THE RESOLUTION TRIAL Intern Sender Juice
DATABRIEF Intern Sender Juice
EXPANDED ACCESS Intern Sender Juice
SCIENCE Intern Sender Juice
NEXT REVOLUTION IN CELL THERAPY Intern Sender Juice
PLATFORM FOR TOMORROW Intern Sender Juice
ON-DEMAND AVAILABILITY Intern Sender Juice
SCIENTIFIC PUBLICATIONS Intern Sender Juice
ABOUT US Intern Sender Juice
AT A GLANCE Intern Sender Juice
MANAGEMENT TEAM Intern Sender Juice
BOARD OF DIRECTORS Intern Sender Juice
SCIENTIFIC ADVISORS Intern Sender Juice
PARTNERS Intern Sender Juice
CORPORATE RESPONSIBILITY Intern Sender Juice
NEWS CENTER Intern Sender Juice
PRESS RELEASES Intern Sender Juice
EVENTS Intern Sender Juice
PERSPECTIVES Intern Sender Juice
SOCIAL MEDIA Intern Sender Juice
COMMUNITY GUIDELINES Intern Sender Juice
INVESTORS Intern Sender Juice
NEWS & EVENTS Intern Sender Juice
PRESS RELEASES Intern Sender Juice
EVENTS Intern Sender Juice
PRESENTATIONS Intern Sender Juice
STOCK QUOTE & CHART Intern Sender Juice
HISTORIC PRICE LOOKUP Intern Sender Juice
INVESTMENT CALCULATOR Intern Sender Juice
DOCUMENTS & CHARTERS Intern Sender Juice
BOARD OF DIRECTORS Intern Sender Juice
MANAGEMENT Intern Sender Juice
COMMITTEE COMPOSITION Intern Sender Juice
SEC FILINGS Intern Sender Juice
INVESTOR FAQs Intern Sender Juice
EMAIL ALERTS Intern Sender Juice
IR INQUIRY Intern Sender Juice
Allogene Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Update Intern Sender Juice
Allogene Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update Intern Sender Juice
Allogene Therapeutics Announces Participation in Upcoming Investor Conferences Intern Sender Juice
Allogene Therapeutics Positions 2026 as a Program-Defining Year for Scalable, Real-World Allogeneic CAR T Intern Sender Juice
Allogene Therapeutics Reports Favorable Result for Servier in Arbitration with Cellectis Intern Sender Juice
Allogene Therapeutics Announces Participation in Upcoming Investor Conferences Intern Sender Juice
Allogene Therapeutics Reports Third Quarter 2025 Financial Results and Business Update Intern Sender Juice
Allogene Therapeutics Announces ALPHA3 Trial-in-Progress Poster Presentation at ASH Annual Meeting Intern Sender Juice
Allogene Therapeutics to Report Third Quarter 2025 Financial Results and Provide Business Update Intern Sender Juice
Allogene Therapeutics Announces Participation in Upcoming Investor Conference Intern Sender Juice
Allogene Therapeutics Reports Second Quarter 2025 Financial Results and Business Update Intern Sender Juice
Allogene Therapeutics to Report Second Quarter 2025 Financial Results and Provide Business Update Intern Sender Juice
View Map Intern Sender Juice
Contact Us Intern Sender Juice
PIPELINE Intern Sender Juice
AlloCAR T Product Pipeline Intern Sender Juice
Expanded Access Intern Sender Juice
Scientific Publications Intern Sender Juice
At a Glance Intern Sender Juice
Management Team Intern Sender Juice
Press Releases Intern Sender Juice
Events Intern Sender Juice
Perspectives Intern Sender Juice
Social Media Intern Sender Juice
Corporate Governance Intern Sender Juice
INVESTORS Intern Sender Juice
TERMS OF USE Intern Sender Juice
PRIVACY NOTICE Intern Sender Juice

SEO Nøgleord

Nøgleords cloud

therapeutics events cell management car trial learn allogeneic allogene more

Nøgleords balance

Nøgleord Indhold Titel Nøgleord Beskrivelse Overskrifter
learn 17
more 16
allogene 12
therapeutics 12
cell 10

Brugervenlighed

Link

Domæne : allogene.com

Længde : 12

FavIkon

Godt, din side har et FavIcon!

Printervenlighed

Vi kunne ikke finde en printer venlig CSS skabelon.

Sprog

Godt, dit tildelte sprog er en.

Dublin Core

Denne side benytter IKKE Dublin Core principperne.

Dokument

Dokumenttype

HTML 5

Kryptering

Perfekt. Dit Charset er tildelt UTF-8.

W3C Validering

Fejl : 0

Advarsler : 0

Email Privatliv

Advarsel! Mindst én email adresse er blevet fundet i rå tekst. Brug gratis antispam beskytter for at hemme din email fra spammere.

Udgået HTML

Godt! Vi har ikke fundet udgåede HTML tags i din kildekode

Hastigheds Tips

Alle tiders! Din webside bruger ikke nestede tabeller.
Advarsel! Din webside benytter inline CSS kode!
Dårligt, din webside har for mange CSS filer (mere end 4).
Dårligt, din webside har for mange JavaScript filer (mere end 6).
Perfekt, din hjemmeside udnytter gzip.

Mobil

Mobil Optimering

Apple Ikon
Meta Viewport Tag
Flash indhold

Optimering

XML Sitemap

Stor, din hjemmeside har en XML sitemap.

https://allogene.com/sitemap_index.xml

Robots.txt

https://allogene.com/robots.txt

Stor, din hjemmeside har en robots.txt-fil.

Analytics

Stor, din hjemmeside har et analyseværktøj.

   Google Analytics

PageSpeed Insights


Apparat
Kategorier

Free SEO Testing Tool

Free SEO Testing Tool er et gratis SEO redskab der hjælper med din hjemmeside